Atara Biotherapeutics (ATRA) Free Cash Flow Growth (5y) (2018 - 2026)
Atara Biotherapeutics (ATRA) Free Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,824.80 Bn | 1,824.74 Bn | - |
| 2 | Akari Therapeutics | 955.99 Bn | 955.99 Bn | - |
| 3 | BeOne Medicines | 473.90 Bn | 469.11 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.79 Bn | 116.54 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.64 Bn | 62.88 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.78 Bn | 62.78 Bn | - |
| 7 | Argenx Se | 55.45 Bn | 50.27 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.16 Bn | 37.16 Bn | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.16% |
| Dec 31, 2025 | -3.83% |
| Sep 30, 2025 | 28.79% |
| Jun 30, 2025 | 34.06% |
| Mar 31, 2025 | 16.27% |
| Dec 31, 2024 | 16.74% |
| Sep 30, 2024 | 40.76% |
| Jun 30, 2024 | 27.59% |
| Mar 31, 2024 | 16.04% |
| Dec 31, 2023 | 2.62% |
| Sep 30, 2023 | -1.90% |
| Jun 30, 2023 | -16.71% |
| Mar 31, 2023 | 6.70% |
| Dec 31, 2022 | -12.21% |
| Sep 30, 2022 | -27.94% |
| Jun 30, 2022 | -21.28% |
| Mar 31, 2022 | -30.25% |
| Dec 31, 2021 | -12.13% |
| Sep 30, 2021 | -27.03% |
| Jun 30, 2021 | -41.32% |